男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

穿孔素1(PRF1)重組蛋白

Recombinant Perforin 1 (PRF1)

FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein

  • 穿孔素1(PRF1)重組蛋白產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)重組蛋白產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)重組蛋白Figure . Gene Sequencing (extract)
  • RPB317Mu02.jpgFigure. SDS-PAGE
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào)適用物種:Mus musculus (Mouse,小鼠)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB317Mu01穿孔素1(PRF1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB317Mu02穿孔素1(PRF1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APB317Mu01穿孔素1(PRF1)活性蛋白Cell?culture;?Activity?Assays.
APB317Mu02穿孔素1(PRF1)活性蛋白Cell?culture;?Activity?Assays.
PAB317Mu01穿孔素1(PRF1)多克隆抗體WB; IHC; ICC; IP.
PAB317Mu02穿孔素1(PRF1)多克隆抗體WB; IHC; ICC; IP.
LAB317Mu81穿孔素1(PRF1)多克隆抗體(異硫氰酸熒光素標(biāo)記)WB; IHC; ICC; IF.
LAB317Mu71穿孔素1(PRF1)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
WEB317Mu穿孔素1(PRF1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍)Enzyme-linked immunosorbent assay for Antigen Detection.
SEB317Mu穿孔素1(PRF1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB317Mu穿孔素1(PRF1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
Diagnostic Microbiology and Infectious DiseaseGranzyme B as a diagnostic marker of tuberculosis in patients with and without HIV coinfection[Pubmed:26915636]
FASEB?JOURNALThe immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis[Pubmed: 30951375]
TheranosticsA novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors[Pubmed: 31695790]
Mol ImmunolCD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection[Pubmed: 33223223]
INVESTIGATIONAL NEW DRUGSDual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors[Pubmed: 32772342]
Am J Transl ResCombined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma[34377237]
Nat Biomed EngCancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy[34873307]
J Exp MedSingle-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion[Pubmed:35061012]